| Literature DB >> 24827651 |
Stephanie Verstappen1, Dick Mul1.
Abstract
We report a case of a 6-week-old infant with diabetes mellitus based on a genetic defect in the sulfonylurea receptor 1 (SUR1), an ATP-sensitive potassium (KATP) channel protein. A spectacular improvement in glucose regulation was shown by real-time continuous glucose monitoring when switching her from insulin to oral glibenclamide. Children with neonatal onset of diabetes deserve genetic testing in order to replace insulin with oral medication. 2014 BMJ Publishing Group Ltd.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24827651 PMCID: PMC4025244 DOI: 10.1136/bcr-2013-202912
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X